HC Surgical Specialists' 1H earnings surge to $2.5 mil on newly acquired subsidiaries

HC Surgical Specialists' 1H earnings surge to $2.5 mil on newly acquired subsidiaries

Stanislaus Jude Chan
09/01/18, 06:57 pm

SINGAPORE (Jan 9): Medical services group HC Surgical Specialists saw its earnings surge to $2.5 million for the 1H2018 ended November, from $0.1 million a year ago.

Excluding one-off items incurred in 1H2017, including IPO expenses, interest on redeemable convertible loan and fair value gain on derivative financial instruments, HCSS would have seen earnings of $1.5 million a year ago.

The increase was on the back of an 80% growth in revenue to $7.7 million in 1H18, largely due to the capturing of the full six months contributions from new subsidiaries.

Employee benefits expense increased by 93.3% to $2.6 million, mainly attributable to increased headcount from new subsidiaries acquired or incorporated.

Other expenses decreased by 18.6% to $1.6 million, mainly due to one-off IPO expenses of $1.3 million incurred in 1HFY2017. This was partially offset by higher allowance for impairment loss on doubtful investee non-trade receivables of $361,000 and operating expenses incurred by new subsidiaries acquired or incorporated.

As at end November, cash and cash equivalents stood at $5.4 million.

HCSS has declared an interim dividend of 1.1 cent per share for the period, payable on Jan 30. This is lower than the dividend of 1.8 cents per share paid in the corresponding period a year ago.

“We are encouraged by the results which are attributed to both organic and inorganic growth and are optimistic with the future,” says HCSS executive director and CEO Heah Sieu Min.

Heah adds that the group will continue to look for collaborative opportunities both locally and regionally, including further expansion into heartland areas.

Shares of HCSS closed flat at 72 cents on Tuesday.

Time to 'buy' MindChamps as growth initiatives bear fruit: RHB

SINGAPORE (May 27): RHB Research continues to keep MindChamps Preschool at “buy” at a lower target price of 83 cents compared to 87 cents previously, indicating a 26% upside plus 2.2% yield. The reduced target price comes after cutting FY19-20F earnings by 7% and 11%, respectively, upon management indications that adopting SFRS 16 has negatively impacted the group’s 1Q19 pre-tax profit by about $90 million or -15%. In a May 17 report, analyst Juliana Cai says she nonetheless remains positive on MindChamps as she expects the group to start reaping returns from its investments as its....

Ascendas-Singbridge establishes co-innovation lab with IMDA & Enterprise Singapore

SINGAPORE (May 27): Singapore’s smart nation ambitions have been further bolstered by a new partnership between Ascendas-Singbridge, Infocomm Development Authority of Singapore (IMDA) and Enterprise Singapore (ESG) to form the Smart Urban Co-Innovation Lab. All three parties are looking to have a total of 30 co-innovation projects come out from the lab, which is expected to be launched at the end of the year as the first developer-led lab in Southeast Asia. This announcement follows last year’s call for innovation led by IMDA, Ascendas and JTC. Ascendas has published 12 probl....

Frasers Centrepoint Trust poised to ride on popularity of suburban retail malls, analysts say

SINGAPORE (May 27): Suburban retail malls are quickly gaining favour in Singapore, stealing local visitors away from the famed Orchard Road shopping belt. And Frasers Centrepoint Trust (FCT), which currently owns a portfolio of six suburban malls, looks poised to capitalise on this trend. Already in FCT’s suburban mall portfolio are Causeway Point, Northpoint City North Wing, Changi City Point, YewTee Point, Anchorpoint, and Bedok Point. The retail REIT has also proposed to acquire the one-third interest in Sapphire Star Trust, which owns the Waterway Point mall in Punggol, from its sp....